Arbutus, Sanofi Escalate mRNA Patent Fights; InnoCare’s TYK2 Contender Advances

Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances

The new lawsuits add to a web of legal disputes over technology involved in COVID vaccines. Elsewhere, a prolific AI biotech inked another deal and Insmed strengthened support for a closely watched blood pressure drug.

Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patents

Sanofi and Arbutus are each going to court over alleged violations of their respective mRNA delivery patents, adding to a growing list of companies making similar complaints. The French pharma is suing Pfizer and Moderna ...

Sanofi joins the mRNA vaccine patent wars - European Biotechnology Magazine

Sanofi has sued Pfizer and Moderna, alleging that their COVID-19 and respiratory syncytial virus (RSV) vaccines infringe patents covering the delivery of messenger RNA using lipid nanoparticles it acquired through the acquisition of Translate Bio in 2021. The post Sanofi joins the mRNA vaccine patent wars appeared first on European Biotechnology Magazine.